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Purpose: MicroRNAs (miRNAs) are important regulators of many cellular functions due to their ability to target mRNAs
for degradation or translational inhibition. Previous studies have reported that the expression of microRNA-9 (miR-9) is
regulated by retinoic acid and reactive oxygen species (ROS). We have previously shown that N-(4-hydoxyphenyl)-
retinamide (4HPR), a retinoic acid derivative, induces ROS generation and apoptosis in cultured human retinal pigment
epithelial (RPE) cells, known as ARPE-19 cells. The aim of the present study was to investigate the expression of miR-9
in ARPE-19 cells in response to 4HPR treatment, and to identify other miRNAs normally expressed in these cells.
Methods: ARPE-19 cells in culture were treated with 4HPR, the total RNA fractions were isolated, and the expression
of various miRNAs and mRNAs was analyzed using real-time PCR. The miRNA expression profile of ARPE-19 cells
was analyzed using microarray hybridization.
Results: Treatment of ARPE-19 cells with 4HPR resulted in apoptosis characterized by the increased expression of
HMOX1 and GADD153 genes. A twofold increase in the expression of miR-9 was also observed during this response.
Potential binding sites for the transcription factors encoded by CEBPA and CEBPB genes were found to be present in the
putative promoter regions of all three genes encoding miR-9. 4HPR-induced miR-9 expression was associated with parallel
increases in the expression of these transcription factor genes. 5-Aza-2’-deoxycytidine, a methyl transferase inhibitor,
also increased the expression of miR-9 in ARPE-19 cells. Microarray hybridization analysis identified let-7b, let-7a,
miR-125b, miR-24, miR-320, miR-23b, let-7e, and let-7d as the most abundant miRNAs normally expressed in ARPE-19
cells. These miRNAs are known to regulate cell growth, differentiation or development. The 4HPR treatment increased
the expression of miR-16, miR-26b, miR-23a, and miR-15b in ARPE-19 cells, although these increases were modest when
compared to the increase in the expression of miR-9.
Conclusions: Our studies demonstrate that miR-9 is expressed in the RPE cell line ARPE-19, and its expression is
increased by a retinoic acid derivative and by an inhibitor of promoter hypermethylation. Several miRNAs with inherent
ability to regulate cell growth, differentiation and development are also normally expressed in ARPE-19 cells. Thus, miR-9
and other miRNAs could be important in maintaining RPE cell function.
MicroRNA  (miRNA)  is  a  class  of  single-stranded
noncoding small (~22 nucleotides) RNA molecules known to
regulate  gene  expression  posttranscriptionally  [1,2].  The
miRNAs,  encoded  by  genes  localized  to  various
chromosomes, are initially transcribed as primary transcripts
(pri-miRNAs),  then  converted  to  pre-miRNAs  and
subsequently  processed  to  mature  miRNAs,  which  are
essential components of the RNA-initiated silencing complex
(RISC).  An  miRNA  can  function  as  a  posttranscriptional
silencer of gene expression either by destabilizing its target
transcripts  or  by  inhibiting  their  translation.  A  perfect
Correspondence to: R. Krishnan Kutty, Laboratory of Retinal Cell
and Molecular Biology, Bldg. 6, Room 112, National Eye Institute,
National Institutes of Health, 6 Center Dr., MSC 0608, Bethesda,
MD, 20892; Phone: (301) 451-1962; FAX: (301) 402-1883; email:
kuttyk@nei.nih.gov
complementarity between the miRNA and its target mRNA
often results in the rapid degradation of the latter. A single
miRNA can bind to the 3′-untranslated region (3′UTR) of
many  target  gene  transcripts  and  thereby  inhibit  their
translation. The translational repression requires only a partial
complementarity between the miRNA and its target mRNAs
[2]. Recent studies have identified miR-9 as one such miRNA
with  an  important  role  in  cell  growth,  differentiation,
neurogenesis, immunity and oncogenesis due to its ability to
target  translational  inhibition  of  many  genes,  including
ONECUT2  (one  cut  homeobox  2),  REST  (RE1-silencing
transcription factor), TLX (NR2E1, nuclear receptor subfamily
2, group E, member 1), and NFKB1 (nuclear factor of kappa
light  polypeptide  gene  enhancer  in  B-cells)  [3-9].  The
expression of miR-9 is generally suppressed in cases of cancer
due to hypermethylation of the promoter regions of genes
encoding it [10-13]. The expression of miR-9 is altered in
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1475brains  affected  by  Alzheimer  disease,  and  BACE1/beta-
secretase  is  a  target  for  translational  inhibition  by  this
microRNA  [14,15].  Decreased  expression  of  miR-9  is
observed in presenilin-1 null mice [16]. Its expression is also
reported to be regulated by retinoic acid, oxidative stress,
alcohol and pro-inflammatory agents [7,9,17-19].
A normally functioning retinal pigment epithelium (RPE)
is indispensible for vision, and impaired function as a result
of oxidative stress is thought to be a major factor responsible
for the development of retinal degenerative diseases, such as
age-related macular degeneration [20]. ARPE-19, a cell line
derived from human RPE, has been widely used to investigate
the response of RPE to oxidative stress [21-25]. A previous
study from our laboratory has shown that the retinoic acid
derivative  N-(4-hydroxyphenyl)  retinamide  (4HPR,
fenretinide)  can  generate  oxidative  stress,  increase  the
expression of HMOX1 (heme oxygenase [decycling] 1) and
GADD153  (DDIT3,  DNA-damage-inducible  transcript  3)
genes and subsequently induce apoptosis in ARPE-19 cells
[26]. We reasoned that miR-9 expression could be altered
during  this  process  since  its  expression  is  reported  to  be
regulated by both retinoic acid and oxidative stress [9,17,18].
Therefore,  we  investigated  the  expression  of  miR-9  in
ARPE-19 cells in response to 4HPR-induced HMOX1 and
GADD153 expression and apoptosis. We then identified other
miRNAs  normally  expressed  in  ARPE-19  cells  using
microarray analysis and determined if the expression levels of
some of these miRNAs were also affected by 4HPR.
METHODS
Cell culture: The ARPE-19 human RPE cell line at passage
18  was  obtained  from  ATCC  (Manassas,  VA)  and  the
experiments were performed using cells from passages 20
through 24. The cells were grown in Dulbecco's modified
Eagle's medium containing nutrient mixture F12, 50/50 mix
(Cellgro, Herndon, VA) supplemented with 5% fetal bovine
serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM
non-essential  amino  acids  and  penicillin  (100  U/ml)  and
streptomycin (100 μg/ml), as described previously [26]. Cells
were seeded onto tissue culture plates at a density of 2×105
cells/ml in complete medium and allowed to grow at 37 °C in
a humidified environment of 5% CO2 in air to reach about 80%
confluence (1–2 days). The culture medium was then replaced
with fresh serum-free medium containing penicillin (100 U/
ml) and streptomycin (100 μg/ml) before treating the cells
with various agents.  N-(4-hydroxyphenyl)retinamide (4HPR)
was purchased from Biomol (Plymouth Meeting, PA) and
dissolved at a concentration of 10 mM in DMSO before being
added to the cell culture medium to the required concentration.
The controls received an equal volume of vehicle. Treatments
were performed under subdued light and other conditions for
24 h, as reported previously [26]. The ARPE-19 cells were
treated  with  5-aza-2’-deoxycytidine  (Sigma-Aldrich,  St.
Louis, MO). The compound was first dissolved in DMSO
before  adding  it  to  the  cell  culture  medium  to  a  final
concentration  of  1  µM.  This  treatment  lasted  3  days,  the
culture medium being replaced every 24 h with fresh medium
containing  the  compound.  Sodium  meta-arsenite  and
menadione were obtained from Sigma-Aldrich, their stock
solutions were prepared in water and the cells were treated
with these compounds for 24 h.
Apoptosis ELISA: Detection of apoptosis in ARPE-19 cells
was  performed  by  quantitative  sandwich-enzyme-
immunoassay using mouse monoclonal antibodies directed
against DNA and histones (Cell Death Detection Elisa kit;
Roche,  Indianapolis,  IN),  as  previously  described  [26].
ARPE-19 cells were grown on 24-well tissue culture plates,
treated with 4HPR for 24 h, and lysed by incubating with lysis
buffer (250 µl/well) for 30 min at room temperature. The cell
lysates were then centrifuged at 250× g for 10 min, and 10 µl
aliquots of supernatants were removed and analyzed using
ELISA. The absorbance at 405 nm was measured using a
Victor2 Multilabel Counter (Perkin Elmer, Waltham, MA).
Microarray analysis: Microarray hybridization analysis was
performed  using  NCode  miRNA  Expression  Profiling
Services (Invitrogen, Carlsbad, CA). Total RNA was isolated
from untreated ARPE-19 cells using TRIzol Reagent, and its
quality  analyzed  using  agarose  gel  electrophoresis.  Small
RNA was enriched from total RNA (20 μg) using the PureLink
miRNA Isolation Kit. The enriched miRNA fraction (2.4 μg)
was Poly(A) tailed, labeled with Alexa Fluor (NCode miRNA
Labeling System) and hybridized to NCode Multi-Species
miRNA Microarrays for 4 h at 62 °C. Two RNA samples were
analyzed  using  this  procedure  on  different  microarrays
containing  duplicate  spots  of  each  miRNA  probe.
Hybridization  and  washing  of  the  arrays  were  performed
according  to  the  standard  protocol  described  in  NCode
miRNA Labeling System Manual. The arrays were scanned
on a GenePix 400B Microarray Scanner (Molecular Devices,
Sunnyvale, CA) and images were then analyzed using the
GenePix software.
Quantitative  real-time  RT–PCR  analysis:  For  quantitative
real-time RT–PCR analysis of various transcripts, 2 µg of total
RNA extracted from ARPE-19 cells with RNeasy Protect
Mini  Kit  (Qiagen,  Valencia,  CA)  was  reverse  transcribed
using  the  High  Capacity  cDNA  Archive  Kit  (Applied
Biosystems, Foster City, CA). After reverse transcription, 5 µl
of cDNA was used as a template for quantitative real-time
PCR, which was performed on an Applied Biosystems 7500
Real-Time PCR System using TaqMan Universal PCR Master
Mix  and  other  reagents  from  Applied  Biosystems.  The
manufacturer's  default  thermal  cycling  conditions  were
followed. Each PCR reaction (20 µl) was set up by using
validated TaqMan probes (labeled with reporter dye FAM at
the 5′ end) and primers specific for each gene (GADD153,
HMOX1,  CEBPA,  CEBPB,  and  TGM2  with  assay
identification  numbers  Hs00358796_g1,  Hs00157965_m1,
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1476Hs00269972_s1,  Hs00270923_s1,  and  Hs00190278_m1,
respectively). A human GAPDH (part number: 4352934E)
gene was used as the endogenous control. Gene amplification
data were analyzed using Applied Biosystems 7500 System
Sequence Detection Software version 1.2.3. The results were
expressed as n-fold induction in gene expression, calculated
using the ΔΔCT method.
For  real-time  PCR  analysis  of  miRNAs,  total  RNA
fraction containing miRNAs was prepared from ARPE-19
cells using miRNeasy Mini Kit (Qiagen). RT–PCR analysis
was performed on an Applied Biosystems 7500 Real-Time
PCR System using individual TaqMan MicroRNA Assays
(miR-107,  miR-125b,  miR-15a,  miR-16,  miR-193b,
miR-210,  let-7a,  let-7c,  let-7d,  miR-98,  miR-9,  miR-34a,
miR-26b, miR-24, miR-23a, miR-223, miR-15b, miR-128a,
miR-204,  or  miR-224),  TaqMan  MicroRNA  Reverse
Transcription Kit and TaqMan Universal PCR Master Mix,
No AmpErase UNG (Applied Biosystems). RNU48 was used
as  the  endogenous  control  and  the  ΔΔCT  method  was
employed to estimate miRNA expression.
The expression of selected miRNAs in ARPE-19 cells
was  verified  by  real-time  PCR  employing  NCode  SYBR
Green  miRNA  qRT–PCR  Kit  and  NCode  miRNA  First-
Strand cDNA Synthesis Kit (Invitrogen). Total RNA samples
(1 μg) were first treated with DNase I and then subjected to a
polyadenylation reaction before first strand cDNA synthesis
with SuperScript III and Universal RT Primer (Invitrogen).
Each PCR reaction was performed using a forward primer
specific for the tested miRNA and the Universal qPCR Primer.
The  miRNAs  were  analyzed  and  their  forward  primer
sequences were determined as: let-7b, TGA GGT AGT AGG
TTG TGT GGT T; miR-125b, TCC CTG AGA CCC TAA
CTT GTG A; miR-24, TGG CTC AGT TCA GCA GGA ACA
G; miR-23b, ATC ACA TTG CCA GGG ATT ACC; let-7e,
TGA GGT AGG AGG TTG TAT AGT; miR-210, CTG TGC
GTG TGA CAG CGG CTG A; miR-193B, AAC TGG CCC
TCA AAG TCC CGC TTT; miR-423–3P, AGC TCG GTC
TGA  GGC  CCC  TCA  G.  For  the  analysis  of  statistical
significance, Student’s paired t-test was used. All values have
been expressed as mean±SD, n=4; p<0.05 denotes statistically
significant differences. The results shown are representative
of three different experiments.
Search for potential transcription factor binding sites: DNA
sequences (1 kb) upstream of the genes transcribing miR-9 or
other miRNAs were examined for the presence of potential
transcription factor binding sites. The following Web-based
software packages were used, each with default parameters:
TESS - Transcription Element Search System [27] and the
MatInspector program from Genomatix.
RESULTS
Figure 1. Increased miR-9 expression in ARPE-19 cells during 4HPR-induced apoptosis and the expression of HMOX1 and GADD153.
ARPE-19 cells were treated with indicated concentrations of 4HPR for 24 h, and real-time RT–PCR was employed to analyze the expression
of miR-9, HMOX1 and GADD153. Formation of mono- and oligonucleosomes was estimated using ELISA as a marker for apoptosis. A:
4HPR increased miR-9 expression. B: 4HPR-induced apoptosis as indicated by the generation of mono- and oligonucleosomes. C: 4HPR-
induced HMOX1 expression. D: 4HPR-induced GADD153 expression. *p<0.05 compared to control, n=4.
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1477We analyzed the expression of miR-9 in ARPE-19 cells in
response  to  4HPR  treatment.  The  cells  were  treated  with
varying concentrations of 4HPR for 24 h, and the miR-9
expression  was  measured  using  real-time  RT–PCR.  An
increase in miR-9 expression was observed with increasing
concentration of 4HPR (Figure 1). A ~2 fold increase in miR-9
expression was detected when the concentration of 4HPR
reached 10 µM. Dimethyl sulfoxide, the vehicle used in this
study to dissolve 4HPR, had no effect on the miR-9 expression
by itself. ARPE-19 cells from passages 20 to 24 did not show
detectable variation in miR-9 expression or its response to
4HPR  treatment  (data  not  shown).  The  4HPR  treatment
induced apoptosis, as expected, as indicated by the generation
of mono- and oligonucleosomes in the treated cells. We also
analyzed the expression of two genes, HMOX1 (a marker for
oxidative stress) and GADD153, since we have previously
shown that their expression is highly increased during 4HPR-
induced  apoptosis  of  ARPE-19  cells  [26].  The  4HPR-
dependent increase in miR-9 expression paralleled increases
in the expression of HMOX1and GADD153. Thus, treatment
of ARPE-19 cells with 4HPR induces expression of miR-9
along  with  established  markers  of  oxidative  stress  and
apoptosis.
Figure 2. MiR-9 expression in ARPE-19 cells is not affected by
oxidative stress. The cells were treated for 24 h with menadione (20
μM) or sodium arsenite (2 μM), agents known to cause oxidative
stress. The expression of miR-9 and HMOX1, a marker for oxidative
stress, was analyzed using real-time RT–PCR. A: MiR-9 expression
was not affected by menadione and arsenite. B: HMOX1 expression
was  markedly  increased,  as  expected,  by  both  menadione  and
arsenite. *p<0.05 compared to control, n=4.
The miR-9 expression in ARPE-19 cells in response to
4HPR treatment was further investigated. Earlier work from
our laboratory has shown that 4HPR-induced apoptosis of
ARPE-19 cells is preceded by reactive oxygen species (ROS)
generation  [26].  The  increase  in  HMOX1  expression  is  a
consequence of oxidative stress. We examined the possibility
that  the  observed  increase  in  the  expression  of  miR-9  in
4HPR-treated cells is mediated by oxidative stress, rather than
by  4HPR  directly.  ARPE-19  cells  were  treated  with
menadione  and  sodium  arsenite,  agents  known  to  cause
oxidative  stress,  and  the  miR-9  expression  and  HMOX1
expression were then analyzed. Both of these agents induced
HMOX1 expression as expected, but the miR-9 expression
was  not  affected  significantly  (Figure  2).  Thus,  oxidative
stress per se does not appear to mediate the effect of 4HPR on
miR-9 expression.
We analyzed the putative promoter regions of three genes
encoding miR-9 for regulatory elements. As shown in Figure
3,  potential  binding  sites  for  CCAAT/enhancer  binding
protein (CEBP) transcription factors, CEBP-α and CEBP-β,
are present in the 5′-flanking regions of MIR9–1, MIR9–2, and
MIR9–3 genes. Thus, it is possible that these transcription
factors could regulate the expression of miR-9. As shown in
Figure 4, the increase in the expression of miR-9 due to 4HPR
is  associated  with  parallel  increases  in  the  expression  of
CEBPA  and  CEBPB,  the  genes  encoding  CEBP-α  and
CEBPB-β, respectively.
The expression of miR-9 genes could be suppressed by
the  hypermethylation  of  their  promoter  regions  [10].
Treatment  of  cells  with  5-aza-2’-deoxycytidine,  a  methyl
transferase  inhibitor,  can  alleviate  this  suppression.  The
expression  of  miR-9  in  ARPE-19  cells  increased
approximately threefold in response to the treatment (Figure
5). TGM2, a gene known to be regulated by hypermethylation
[28], was also induced as expected.
We next used microarray hybridization analysis to obtain
a broad view of the microRNA species normally expressed in
ARPE-19 cells. Small RNA preparation, which was enriched
from total RNA isolated from untreated ARPE-19 cells, was
employed  for  hybridization  analysis  on  a  microarray
containing  duplicate  spots  of  each  miRNA  probe.  The
microarray  analysis,  when  repeated  using  a  second  RNA
sample,  yielded  similar  results.  The  microarray  data  are
provided at GEO (GSE23107). The relative expression levels
of 62 miRNA (out of 366 human miRNAs tested) expressed
substantially in these cells are shown in Figure 6. The most
abundant miRNAs expressed in ARPE-19 cells were let-7b,
let-7a, miR-125b, miR-24, miR-320, miR-23b, let-7e, and
let-7d. The microarray analysis failed to detect the miR-9
expression in ARPE-19 cells. This could be due to the limited
sensitivity of microarray analysis in comparison to real-time
RT–PCR, where the target is detected after multiple cycles of
amplification.
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1478Figure 4. 4HPR-induced expression of miR-9 in ARPE-19 cells is
associated with increased expression of CEBPA and CEBPB. The
cells were treated with 10 μM of 4HPR for 24 h, and the gene
expression  was  analyzed  using  real  time  RT–PCR.  A:  4HPR
increased miR-9 expression. B: 4HPR increased CEBPA expression.
C:  4HPR  increased  CEBPB  expression.  *p<0.05  compared  to
control, n=4.
The microarray results were validated by analyzing the
expression of selected miRNAs using real-time PCR analysis.
Let-7b, miR-125b, miR-24, miR-23b, and let-7e represented
the  most  abundant  ones,  while  miR-210,  miR-193b  and
miR-423  represented  the  less  abundant  ones.  The
amplification and dissociation plots (Figure 7) clearly indicate
that all the miRNAs tested are present in the RNA preparations
obtained from the ARPE-19 cells. Several miRNAs expressed
in ARPE-19 cells are also reported or predicted to be neural
retina-specific (Figure 8).
Figure 5. Expression of miR-9 increases in ARPE-19 cells following
treatment with 5-aza-2’-deoxycytidine. Cells were treated with 1
μM 5-aza-2’-deoxycytidine for 3 days, and miR-9 expression was
estimated using real time RT–PCR. The expression of TGM2, a gene
known to be upregulated by this treatment, was also analyzed. A: 5-
aza-2’-deoxycytidine  increased  miR-9  expression.  B:  5-aza-2’-
deoxycytidine increased TGM2 expression. *p<0.05 compared to
control, n=4.
Figure 3. Sequences matching putative
binding  sites  for  CEBP  transcription
factors  are  present  in  the  5′-flanking
regions of all three human miR-9 genes.
DNA sequences (1 kb) upstream of the
miR-9  genes  were  analyzed  for  the
presence  of  potential  transcription
factor binding sites, as described in the
METHODS.
Molecular Vision 2010; 16:1475-1486 <http://www.molvis.org/molvis/v16/a161> © 2010 Molecular Vision
1479Figure  6.  Microarray  hybridization  analysis  of  miRNAs  normally  expressed  in  ARPE-19  cells.  The  data  shown  is  representative  of
hybridization analyses performed using two RNA samples isolated from untreated ARPE-19 cells. The microarrays contained duplicate spots
for each miRNA probe. The average fluorescence intensities are shown; the view is filtered by name, which has multiple members selected.
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1480Figure 7. Real-time RT–PCR validation of selected miRNAs. Amplification plot (left panel) and dissociation plot (right panel) for the indicated
miRNA are shown.
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1481We  analyzed  the  response  of  selected  miRNAs  in
ARPE-19 cells to 4HPR treatment using real-time RT–PCR
analysis (Figure 9). Most of the miRNAs tested were selected
from microarray results shown in Figure 6 to represent both
the most abundant as well as the less abundant miRNAs. The
miR-98, miR-223, miR-15b, and miR-128a were included to
represent the ones not detected by microarray analysis. We
also tested miR-204 and miR-224 because they are reported
to be expressed in mouse RPE [29,30]. Although all the tested
miRNAs, including miR-204 and miR-224, were found to be
expressed in ARPE-19 cells, the majority did not respond to
4HPR  treatment.  Increases  in  the  expression  of  miR-16,
miR-26b, miR-23a, and miR-15b were observed following
4HPR treatment; however, these increases were modest when
compared to the approximately twofold increase observed for
miR-9. The 5′-flanking regions (~1 kb) of genes generating
miR-16, miR-26b, miR-23a, miR-15b, miR-223, and let-7a
were analyzed for the presence of consensus binding sites for
CEBP-α and CEBP-β. The genes for miR-16, miR-15b, and
miR-223 as well as one of the three genes encoding let-7a were
found to contain potential binding sites for these transcription
factors (data not shown).
DISCUSSION
Although  microRNA  expression  and  function  in  the
mammalian eye has been investigated [29,31-37], information
about miRNA expression and function in the RPE is limited.
An  exception  is  the  reported  detection  of  miR-204  and
miR-224 in mouse RPE using in situ hybridization [29,30].
Here we demonstrate that miR-9 is expressed in ARPE-19
cells, and that its expression is increased when these cells are
exposed to 4HPR. The increase in miR-9 expression by 4HPR
was associated with apoptosis, as indicated by mono- and
oligonucleosomes  formation,  and  with  large  increases  in
HMOX1  and  GADD153  expression.  The  4HPR-induced
apoptosis and increases in GADD153 and HMOX1 expression
in ARPE-19 cells are preceded by an increase in reactive
oxygen  species  generation  in  ARPE-19  cells  [26].  Taken
together, these facts are consistent with a model of miR-9
activation  due  to  reactive  oxygen  species  generated  from
4HPR  treatment.  Indeed,  increase  of  miR-9  expression
following oxidative stress induced by metal sulfates has been
reported [18]. However, our results eliminate oxidative stress
as a direct regulator of the miR-9 expression in ARPE-19 cells.
Menadione and arsenite, agents well known to cause oxidative
stress, failed to increase the miR-9 expression in these cells.
In contrast, the expression of HMOX1, a marker for oxidative
stress, was highly increased in cells treated with these agents,
as expected. 4HPR is a derivative of all-trans-retinoic acid,
which has been shown to be a regulator of miR-9 expression
[17]. All-trans-retinoic acid is also known to regulate gene
expression through its effects upon the expression of CEBP
transcription factors [38,39]. Our sequence analysis indicated
that  putative  CEBP  binding  sites  are  present  on  potential
promoter  regions  of  all  three  genes  encoding  miR-9
precursors (MIR9–1, MIR9–2, and MIR9–3). Our observation
that the expression of genes encoding CEBP-α and CEBP-β
increased in ARPE-19 cells in response to 4HPR treatment
suggests that these transcription factors could be involved in
the regulation of miR-9 expression. The 4HPR treatment also
significantly increased the expression of miR-15b, miR-16,
miR-23a, and miR-26b. However, putative binding sites for
CEBP-α and CEBP-β were absent in the promoter regions of
the genes encoding miR-23a and miR-26b. Thus, factors other
than CEBP-α and CEBP-β are indicated in the regulation of
expression of these miRNAs by 4HPR.
Expression of miR-9 is also known to be regulated by
hypermethylation of the promoter regions of genes encoding
this  microRNA.  This  epigenetic  repression  of  miR-9
expression has been reported to be a contributing factor to
breast and colorectal cancer development [10-12]. Our results
show that the miR-9 expression in ARPE-19 cells is regulated
by this mechanism. Treatment of the ARPE-19 cells with 5-
aza-2’-deoxycytidine to block DNA methylation resulted in
increased expression of both miR-9 and TGM2, a gene known
to be regulated by hypermethylation [28]. The potential role
of epigenetic regulation of miR-9 or other microRNAs in RPE
pathophysiology  is  not  yet  known,  although  it  has  been
implicated in cancer and aging [40,41].
The  ability  of  miR-9  to  target  many  genes  for
translational  repression  makes  it  a  potentially  effective
regulator  of  cell  growth,  differentiation,  neurogenesis,
immunity and cancer. There appears to be a large number of
Figure 8. The miRNAs expressed in ARPE-19 cells are compared to
those found in mouse retina, as reported in two separate studies. Blue
circle: ARPE-19 cells. Yellow circle: mouse retina, Xu et al. [37].
Green circle: mouse retina (regulated by ischemia), Shen et al. [55].
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1482potential targets for this microRNA; 936 conserved targets of
miR-9 are reported in TargetScan release 5.2. However, only
a few of them have been verified experimentally. MiR-9 is
reported  to  control  the  secretory  response  of  insulin-
producing  cells  by  diminishing  the  expression  of  the
ONECUT2 transcription factor, a regulator of Granuphilin
expression [3]. The transcription factor REST, a silencer of
neuronal gene expression, is also a target of miR-9 whose
expression  is  downregulated  in  Huntington’s  disease  [4].
MiR-9 is reported to accelerate neural stem cell differentiation
by suppressing the expression of the nuclear receptor TLX
[5]. Another target for miR-9 is BACE1/beta-secretase, whose
activity is elevated in brains affected by Alzheimer disease
[14]. The transcription factor NF-KappaB1 is reported to be
targeted by this microRNA during growth of ovarian cancer
cells  and  in  monocytes  and  neutrophils  exposed  to  pro-
inflammatory agents [6,7]. Several components of the Fgf
signaling  pathway  are  targeted  by  miR-9  during  late
embryonic  development  in  zebrafish  [8].  Translational
repression by miR-9 is also reported for E-cadherin in the SK-
Hep-1 hepatoma cell line [42], Foxg1 in developing mouse
brains [43] and the BK channel splice variant in rat striatal
neurons during alcohol adaptation [19]. ONECUT2 appears
to be an interesting target since it has been reported that this
transcription factor regulates the expression of MITF, a gene
important for RPE physiology [44]. NF-KappaB1 could also
be an important target during the response of RPE to pro-
inflammatory agents or oxidative stress.
We demonstrated using microarray analysis that a large
number of miRNAs are normally expressed in the RPE cell
line, ARPE-19. RT–PCR analysis was employed to verify the
expression of several miRNAs. The most abundant miRNAs
that  were  detected  in  ARPE-19  cells  were  let-7b,  let-7a,
miR-125b, miR-24, miR-320, miR-23b, let-7e, and let-7d.
The let-7 family of microRNAs are important regulators of
differentiation  and  development,  and  their  deregulation  is
often associated with cancer [45,46]. MiR-125b is a novel
regulator of the tumor suppressor p53 [47] as well as many
genes involved in neuronal differentiation [48]. MiR-24 has
been shown to regulate several cell cycle genes, the activin
type 1 receptor ALK4 and dihydrofolate reductase [49-51].
MiR-320 regulates cardiac ischemia/reperfusion injury and
cell  proliferation  by  targeting  heat-shock  protein  20  and
transferrin  receptor  1,  respectively  [52,53].  MiR-23b  is
reported to regulate cell differentiation by targeting Smad
proteins  [54].  The  potential  role  of  these  microRNAs  in
regulating RPE function remains to be elucidated. It should
be  noted  that  microarray  analysis  did  not  detect  miR-9
expression in ARPE-19 cells. The sensitivity of microarray
analysis is highly limited when compared to real-time RT–
PCR, the method we first employed to detect it.
Figure 9. Effect of 4HPR on miRNA
expression in ARPE-19 cells. The cells
were treated with 10 μM 4HPR for 24 h,
and  the  expression  of  miRNAs  was
analyzed using real-time RT–PCR. The
relative  expression  levels  for  each
miRNA in control and treated samples
were estimated and used to calculate the
fold  change.  *p<0.05  compared  to
control, n=4.
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experimental model, it is sensible to determine how well the
population of miRNAs corresponds to what is observed in
retinal  tissue.  Two  groups  of  investigators  have  studied
miRNA  expression  in  mouse  retinas,  using  both  array
hybridization techniques. Among the 69 miRNAs identified
in this study, the 77 reported by Xu et al. [37] and 75 reported
by Shen et al. [55], 30 are common to all three sets. The two
studies based upon extraction of miRNA from retinal tissue
have a total of 40 miRNAs in common. Interestingly, the
ARPE-19 cells have a similar degree of commonality with the
2 data sets from retinas, having 43 in common with each.
The  hybridization  studies  above  have  been
complemented by an informatics approach. Working from a
collection of retinal genes, Arora et al. [33] produced a list of
miRNAs predicted to target the 3′-untranslated regions of
their mRNA sequences. The authors then demonstrated the
expression of a selection of the miRNAs using PCR. Several
of the verified miRNAs are present in all three hybridization
data sets (miR-29, miR-107, let-7d, miR-23a, and miR-143);
three others (miR-124, miR-106, and miR-143) are present in
at  least  one  of  the  hybridization  data  sets.  MiR-135  and
miR-200, although validated, were not found in any of the
hybridization  data  sets.  However,  this  validation  was
performed using PCR, and like miR-9 in the present study, the
expression of miR-135 and miR-200 may be undetectable by
hybridization. Only 10 of the miRNAs found collectively in
the  three  hybridization  studies  were  not  among  those
predicted.  Interestingly,  5  of  these  (miR-184,  miR-210,
miR-31, miR-335, and miR-92) were deemed to be “retina
specific”  in  expression,  according  to  the  tissue  survey
conducted by Xu et al. [37]. Thus, it appears that the predictive
value of the informatics approach is fruitful.
In summary, we have shown that miR-9 is expressed in
the RPE cell line known as ARPE-19 and that its expression
increases  during  4HPR-induced  apoptosis.  The  4HPR-
induced  miR-9  expression  was  associated  with  parallel
increases  in  the  expression  of  CEBPA  and  CEBPB
transcription factor genes. Potential binding sites for these
transcription factors were present in the putative promoter
regions  of  all  three  genes  encoding  miR-9.  The  miR-9
expression in ARPE-9 cells was also increased in response to
treatment with 5-aza-2’-deoxycytidine, a methyl transferase
inhibitor,  thus  indicating  that  the  gene(s)  encoding  this
microRNA  could  be  epigenetically  regulated  via
hypermethylation  of  their  promoter  regions.  Microarray
analysis showed that a large number of miRNAs are normally
expressed in ARPE-19 cells, the most abundant ones being
let-7b, let-7a, miR-125b, miR-24, miR-23b, let-7e, and let-7d.
The miR-9 and other microRNAs could play an important role
in maintaining RPE cell function.
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